51. Diaminopyridine-Based Potent and Selective Mps1 Kinase Inhibitors Binding to an Unusual Flipped-Peptide Conformation
- Author
-
Kazuya Yasuo, Yuki Tachibana, Takahiko Yamamoto, Yuji Sato, Kazuo Ueda, Yataro Daigo, Takeshi Itoh, Takeshi Endoh, Shingo Sakamoto, Yukichi Ishioka, Genta Tadano, Yasuto Kido, Makiko Inoue, Motofumi Iguchi, Masahiro Maeda, Takeshi Shiota, Sachie Tagashira, Masayo Higaki, Kenichi Higashino, Nobuyuki Ide, Keiji Dohi, Yusuke Nakamura, Tooru Wada, Yousuke Okano, Takayuki Kanazawa, Ken-ichi Kusakabe, and Hitoshi Murai
- Subjects
Spindle checkpoint ,Hydrogen bond ,Chemistry ,In vivo ,Stereochemistry ,Kinase ,Organic Chemistry ,Drug Discovery ,Centrosome duplication ,Selectivity ,Biochemistry ,IC50 ,Peptide Conformation - Abstract
Monopolar spindle 1 (Mps1) is an attractive cancer drug target due to the important role that it plays in centrosome duplication, the spindle assembly checkpoint, and the maintenance of chromosomal stability. A design based on JNK inhibitors with an aminopyridine scaffold and subsequent modifications identified diaminopyridine 9 with an IC50 of 37 nM. The X-ray structure of 9 revealed that the Cys604 carbonyl group of the hinge region flips to form a hydrogen bond with the aniline NH group in 9. Further optimization of 9 led to 12 with improved cellular activity, suitable pharmacokinetic profiles, and good in vivo efficacy in the mouse A549 xenograft model. Moreover, 12 displayed excellent selectivity over 95 kinases, indicating the contribution of its unusual flipped-peptide conformation to its selectivity.
- Published
- 2012
- Full Text
- View/download PDF